Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR3 | P32745 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2733772 | 0.83 | ALDH1A1 (0.40) | — | |
| SCHEMBL3443660 | 0.81 | EPHX1 (0.41) | — | |
| SCHEMBL28996539 | 0.78 | LMNA (0.31) | — | |
| SCHEMBL18948680 | 0.77 | OPRL1 (0.34) | SSTR3 | |
| SCHEMBL27523829 | 0.77 | OPRL1 (0.34) | SSTR3 | |
| SCHEMBL9801251 | 0.75 | LMNA (0.31) | — | |
| SCHEMBL9801322 | 0.75 | LMNA (0.31) | — | |
| SCHEMBL27406376 | 0.75 | — | — | |
| SCHEMBL28038986 | 0.75 | SSTR3 (0.36) | SSTR3 | |
| SCHEMBL20680712 | 0.73 | CYP2D6 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612313-B2 | Method for producing lithium halide compound | IDEMITSU KOSAN CO., LTD. (JP) | 2026-04-28 | — | — | US | disclosed |
| US-20260008676-A1 | METHOD FOR MANUFACTURING SULFIDE SOLID ELECTROLYTE | IDEMITSU KOSAN CO.,LTD. (JP) | 2026-01-08 | — | — | US | disclosed |
| US-20250372697-A1 | METHOD FOR PRODUCING SOLID ELECTROLYTE, AND ELECTROLYTE PRECURSOR | IDEMITSU KOSAN CO.,LTD. (JP) | 2025-12-04 | — | — | US | disclosed |
| EP-4657469-A1 | METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE | Idemitsu Kosan Co.,Ltd. (JP) | 2025-12-03 | — | — | EP | disclosed |
| EP-4159678-B1 | METHOD FOR PRODUCING LITHIUM HALIDE COMPOUND | IDEMITSU KOSAN CO (JP) | 2025-10-01 | — | — | EP | disclosed |
| US-12381253-B2 | Solid electrolyte containing a thio-lisicon region II crystal structure | IDEMITSU KOSAN CO., LTD. (JP) | 2025-08-05 | — | — | US | disclosed |
| US-20250201909-A1 | METHOD FOR MANUFACTURING SULFIDE SOLID ELECTROLYTE | IDEMITSU KOSAN CO.,LTD. (JP) | 2025-06-19 | — | — | US | disclosed |
| US-20250183359-A1 | CRYSTALLINE SULFIDE SOLID ELECTROLYTE AND METHOD FOR PRODUCING SAME | IDEMITSU KOSAN CO.,LTD. (JP) | 2025-06-05 | — | — | US | disclosed |
| EP-4564376-A1 | METHOD FOR PRODUCING SOLID ELECTROLYTE, AND SOLID ELECTROLYTE | Idemitsu Kosan Co.,Ltd. (JP) | 2025-06-04 | — | — | EP | disclosed |
| EP-4557317-A1 | METHOD FOR MANUFACTURING SULFIDE SOLID ELECTROLYTE | Idemitsu Kosan Co.,Ltd. (JP) | 2025-05-21 | — | — | EP | disclosed |
| US-20220041444-A1 | METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-02-10 | — | — | US | disclosed |
| US-20210408581-A1 | METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE | IDEMITSU KOSAN CO., LTD. (JP) | 2021-12-30 | — | — | US | disclosed |
| US-20210391596-A1 | METHOD FOR PRODUCING SOLID ELECTROLYTE, AND ELECTROLYTE PRECURSOR | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-12-16 | — | — | US | disclosed |
| US-20210376377-A1 | METHOD FOR PRODUCING SOLID ELECTROLYTE | IDEMITSU KOSAN CO., LTD. (JP) | 2021-12-02 | — | — | US | disclosed |
| US-20210351434-A1 | METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE | IDEMITSU KOSAN CO., LTD. (JP) | 2021-11-11 | — | — | US | disclosed |
| US-11139505-B2 | Method for producing solid electrolyte, and electrolyte precursor | IDEMITSU KOSAN CO., LTD. (JP) | 2021-10-05 | — | — | US | disclosed |
| EP-3886119-A1 | SULFIDE SOLID ELECTROLYTE AND TREATMENT METHOD THEREFOR | Idemitsu Kosan Co.,Ltd. (JP) | 2021-09-29 | — | — | EP | disclosed |
| EP-3886122-A1 | METHOD FOR PRODUCING SOLID ELECTROLYTE, AND ELECTROLYTE PRECURSOR | Idemitsu Kosan Co.,Ltd. (JP) | 2021-09-29 | — | — | EP | disclosed |
| US-20210249685-A1 | METHOD FOR PRODUCING SOLID ELECTROLYTE, AND ELECTROLYTE PRECURSOR | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-08-12 | — | — | US | disclosed |
| US-20210242496-A1 | SULFIDE SOLID ELECTROLYTE AND TREATMENT METHOD THEREFOR | IDEMITSU KOSAN CO., LTD. (JP) | 2021-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008676-A1 | METHOD FOR MANUFACTURING SULFIDE SOLID ELECTROLYTE | CACNA1S, CACNA1A, VRK2 | SSTR3 1353/4885 |
| US-12612313-B2 | Method for producing lithium halide compound | CLCN2, SLC6A12, CLIC1 | SSTR3 421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.